As previously mentioned, the upcoming results should see us regain 52 weeks high ( low 20's ), then gearing up towards 'perfect conditions' trials and FDA exchange.
Share price will increase in steps.
Upcoming results, CNS candidate, extended ocular pipeline, FDA results of next trial run, US funding locked in ( expect this by March ).
By March/ April next year this stock should be traded between 30 and 40 cents, if US funding suprises to the upside make that
60 yo 70 cents..
This happens in gradual market appreciation on each milestone.
Lots to look forward to.
The current job seek ads, same as the ongoing funding and partnering discussions are on the heels of already known positive inhouse
tox studies. We only await outsourced confirmation, as I see it.
all IMO
Ann: Retina Target Engagement Confirmed in Large Eye, page-73
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.0¢ |
Change
0.010(7.69%) |
Mkt cap ! $653.2M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 14.5¢ | 13.0¢ | $1.446M | 10.38M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 252759 | 13.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 113762 | 2 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| PYC (ASX) Chart |